Related references
Note: Only part of the references are listed.Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Jack Antel et al.
ACTA NEUROPATHOLOGICA (2012)
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond
Markus Kipp et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
CytoSolve: A Scalable Computational Method for Dynamic Integration of Multiple Molecular Pathway Models
V. A. Shiva Ayyadurai et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2011)
Experimental models of multiple sclerosis
Andrew R. Pachner
CURRENT OPINION IN NEUROLOGY (2011)
Point-and-Click Cursor Control With an Intracortical Neural Interface System by Humans With Tetraplegia
Sung-Phil Kim et al.
IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING (2011)
Energy failure in multiple sclerosis and its investigation using MR techniques
David Paling et al.
JOURNAL OF NEUROLOGY (2011)
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis
Jeremy Chataway et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Towards molecular imaging of multiple sclerosis
David R. J. Owen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Nonprofit disease groups earmark grants for drug repositioning
Elie Dolgin
NATURE MEDICINE (2011)
Evidence for Polygenic Susceptibility to Multiple Sclerosis-The Shape of Things to Come
William S. Bush et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
An Unusual Cause of Multiple Cerebral Hemorrhages: Drotrecogin Alpha (Activated Protein C): Fig 1.
O. Algin et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla
M. Inglese et al.
BRAIN (2010)
Quality of Life in Multiple Sclerosis: Determinants, Measurement, and Use in Clinical Practice
Deborah M. Miller et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)
Chronic Progressive Multiple Sclerosis - Pathogenesis of Neurodegeneration and Therapeutic Strategies
Dirk Fitzner et al.
CURRENT NEUROPHARMACOLOGY (2010)
Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions
Alan J. Thompson et al.
LANCET NEUROLOGY (2010)
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor et al.
LANCET NEUROLOGY (2010)
Magnetic Resonance Imaging as a Potential Surrogate for Relapses in Multiple Sclerosis: A Meta-analytic Approach
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2009)
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
Andrew D. Goodman et al.
LANCET (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Frederik Barkhof et al.
NATURE REVIEWS NEUROLOGY (2009)
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
F. Sellebjerg et al.
NEUROLOGY (2009)
Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis
Dawn M. Ehde et al.
GENERAL HOSPITAL PSYCHIATRY (2008)
Drug target identification using side-effect similarity
Monica Campillos et al.
SCIENCE (2008)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis
Iris-Katharina Penner et al.
JOURNAL OF NEUROLOGY (2007)
Anxiety disorders and their clinical correlates in multiple sclerosis patients
M. Korostil et al.
MULTIPLE SCLEROSIS (2007)
Functional brain reorganization in multiple sclerosis: Evidence from fMRI studies
P Pantano et al.
JOURNAL OF NEUROIMAGING (2006)
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes
MA Rocca et al.
LANCET NEUROLOGY (2005)
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis
G Pryce et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Training-dependent plasticity in patients with multiple sclerosis
K Morgen et al.
BRAIN (2004)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
Share Paper
